期刊
NEUROLOGY
卷 86, 期 4, 页码 351-359出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0000000000002319
关键词
-
资金
- National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS34447]
- National Human Genome Research Institute [U01 HG004438l]
- Genomics and Randomized Trials (GARNET) Network [U01HG00516-03]
- National Heart, Lung and Blood Institute (NHLBI) [N01-HC-25195]
- NINDS [NS17950]
- NHLBI [U01HL 096917]
- National Institute on Aging (NIA) [AG08122, AG033193]
- National Institute for Health Research [NF-SI-0512-10019] Funding Source: researchfish
Objective:To investigate the genetic contributors to cerebrovascular disease and variation in biomarkers of ischemic stroke.Methods:The Vitamin Intervention for Stroke Prevention Trial (VISP) was a randomized, controlled clinical trial of B vitamin supplementation to prevent recurrent stroke, myocardial infarction, or death. VISP collected baseline measures of C-reactive protein (CRP), fibrinogen, creatinine, prothrombin fragments F1+2, thrombin-antithrombin complex, and thrombomodulin prior to treatment initiation. Genome-wide association scans were conducted for these traits and follow-up replication analyses were performed.Results:We detected an association between CRP single nucleotide polymorphisms (SNPs) and circulating CRP levels (most associated SNP, rs2592902, p = 1.14 x 10(-9)) in 2,100 VISP participants. We discovered a novel association for CRP level in the AKR1D1 locus (rs2589998, p = 7.3 x 10(-8), approaching genome-wide significance) that also is an expression quantitative trait locus for CRP gene expression. We replicated previously identified associations of fibrinogen with SNPs in the FGB and LEPR loci. CRP-associated SNPs and CRP levels were significantly associated with risk of ischemic stroke and recurrent stroke in VISP as well as specific stroke subtypes in METASTROKE. Fibrinogen levels but not fibrinogen-associated SNPs were also found to be associated with recurrent stroke in VISP.Conclusions:Our data identify a genetic contribution to inflammatory and hemostatic biomarkers in a stroke population. Additionally, our results suggest shared genetic contributions to circulating CRP levels measured poststroke and risk for incident and recurrent ischemic stroke. These data broaden our understanding of genetic contributors to biomarker variation and ischemic stroke risk, which should be useful in clinical risk evaluation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据